Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Genzyme

Status and phase: Completed; Phase 3

Conditions: Osteoarthritis, Knee

Treatments: Device: Hylastan

Study type: Interventional

Funder types: Industry

Identifiers

NCT00139295

AVS00103

Details and patient eligibility

About

This is a clinical study to investigate the safety and efficacy of hylastan in treating patients with symptomatic osteoarthritis (OA) of the knee.

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with OA of the knee
• Have tried but not been sufficiently helped by conservative treatment, such as weight reduction and pain medications

Exclusion criteria

• Prior or concomitant treatments that would impede measurement of safety and efficacy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind